Labcorp Holdings Inc. (LH): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-12-31, 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.21B
Year ended 2025-12-31
$1.16B
Trailing 12 months to 2026-06-30
-7.6%
3-year compound annual growth
$2.69B2007-12-31: $567.10M2008-12-31: $624.20M2009-12-31: $747.70M2010-12-31: $757.50M2011-12-31: $709.90M2012-12-31: $667.60M2013-12-31: $616.50M2014-12-31: $535.50M2015-12-31: $726.60M2016-12-31: $918.20M2017-12-31: $1.19B2018-12-31: $925.60M2019-12-31: $1.04B2020-12-31: $1.75B2021-12-31: $2.69B2022-12-31: $1.53B2023-12-31: $874.10M2024-12-31: $1.10B2025-12-31: $1.21B$1.21B
2007-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$1.21B+10.0%2026-02-24, From 2025-01-01
2024-12-31$1.10B+25.4%2026-02-24, From 2024-01-01
2023-12-31$874.10M-42.7%2026-02-24, From 2023-01-01
2022-12-31$1.53B-43.2%2025-02-25, From 2022-01-01
2021-12-31$2.69Bn/c2024-02-26, From 2021-01-01
2020-12-31$1.75B+67.9%2023-02-28, From 2020-01-01
2019-12-31$1.04B+12.8%2022-02-25, From 2019-01-01
2018-12-31$925.60M-21.9%2021-02-25, From 2018-01-01
2017-12-31$1.19B+29.1%2020-02-28, From 2017-01-01
2016-12-31$918.20Mn/c2019-02-28, From 2016-01-01
2015-12-31$726.60M+35.7%2018-02-27, From 2015-01-01
2014-12-31$535.50M-13.1%2016-03-01, From 2014-01-01
2013-12-31$616.50M-7.7%2016-03-01, From 2013-01-01
2012-12-31$667.60M-6.0%2015-02-26, From 2012-01-01
2011-12-31$709.90M-6.3%2014-02-25, From 2011-01-01
2010-12-31$757.50M+1.3%2013-02-26, From 2010-01-01
2009-12-31$747.70M+19.8%2012-02-24, From 2009-01-01
2008-12-31$624.20M+10.1%2011-03-07, From 2008-01-01
2007-12-31$567.10Mn/a2010-02-24, From 2007-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Labcorp Holdings Inc. (LH)2025-12-31$1.21B+10.0%
Quest Diagnostics Inc (DGX)2025-12-31$1.36B+49.5%
Fortrea Holdings Inc. (FTRE)2025-12-31$88.30M-62.8%
Natera, Inc. (NTRA)2025-12-31$109.11M+57.6%
Guardant Health, Inc. (GH)2025-12-31-$233.07Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$66.89Mn/m
Veracyte, Inc. (VCYT)2025-12-31$126.63M+98.5%
Castle Biosciences Inc (CSTL)2025-12-31$28.33M-22.5%
Fulgent Genetics, Inc. (FLGT)2025-12-31-$124.21Mn/m

Compare LH, DGX, FTRE, NTRA side by side · Screen every company in Services-Medical Laboratories ↗